NAMS
NAMS
NASDAQ · Biotechnology

Newamsterdam Pharma Co Nv

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$38.73
+3.88 (+11.13%)
As of May 9, 1:22 AM ET ·
Analyst Consensus
Strong Buy
22
Analysts
High
Coverage
Buy 20 91%
Hold 2 9%
Sell 0 0%
Price Target
Analyst Price Target -6.0% upside
Low Target $23.00
Average Target $36.39
High Target $47.36
Current Price $38.73
Current
$38.73
Target
$36.39
$23.00 $36.39 avg $47.36
Scenario Analysis
Bear Case
$23.00
-40.6%
Low target
Base Case
$36.39
-6.0%
Avg target
Bull Case
$47.36
+22.3%
High target
Risk/Reward
0.5x
Unfavorable
Price in Context
52-Week High
$42.00
-7.8% from high
52-Week Low
$16.79
+130.7% from low
50-Day SMA
$34.11
+13.5% vs SMA
200-Day SMA
$28.53
+35.8% vs SMA
RSI (14)
66.1
Neutral
Target vs 52W High
$36.39
-13.4% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 75% $257.58 +27.8%
AMGN
Amgen Inc
 Hold 44 48% $190.87 -42.5%
GILD
Gilead Sciences Inc
 Strong Buy 39 79% $362.68 +176.2%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 +2.0%
REGN
Regeneron Pharmaceuticals
 Strong Buy 38 79% $76.80 -89.3%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 75% $102.31 -65.3%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -19.5%
INSM
Insmed Inc
 Strong Buy 28 96% $143.40 +41.5%